Antihistamines and azithromycin as a treatment for COVID-19 on primary health care – A retrospective observational study in elderly patients

A common signaling pathway leading to degranulation in mast cells and its regulation by CCR1 ligand

(2020) Hyeun Wook Chang et al.   ALLERGY

Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID‐19

(2020) Bharat Damle et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study

(2020) Daniel E. Freedberg et al.   GASTROENTEROLOGY

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

(2020) Philippe Gautret et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Hydroxychloroquine and Azithromycin to Treat Patients With COVID‐19: Both Friends and Foes?

(2020) Bruno Mégarbane et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria ( BIFAP) : A data resource for pharmacoepidemiology in Spain

(2020) Miguel‐Angel Maciá‐Martínez et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy

(2020) JM. Scherrmann   AAPS Journal

Azithromycin and COVID‐19: Prompt early use at first signs of this infection in adults and children, an approach worthy of consideration

(2020) Robert A. Schwartz et al.   Dermatologic Therapy

Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series

(2020) Tobias Janowitz et al.   GUT

Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?

(2020) Julian D Machiels et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Widely available lysosome targeting agents should be considered as potential therapy for COVID-19

(2020) J. Homolak et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

(2020) Pedro Mondejar-Lopez et al.   RESPIRATORY MEDICINE

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

(2020) Franck Touret et al.   Scientific Reports

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

(2020) Muhammad Adnan Shereen et al.   Journal of Advanced Research

Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19

(2020) Jeffrey F. Mather et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients

(2020) Reed B. Hogan II et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial

(2020) Hamid Reza Samimagham et al.   Trials

Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process

(2019) Dat Huu Tran et al.   JOURNAL OF ANTIBIOTICS

Cardiac safety of second‐generation H 1 ‐antihistamines when updosed in chronic spontaneous urticaria

(2019) Mauro Cataldi et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Erythromycin Estolate Inhibits Zika Virus Infection by Blocking Viral Entry as a Viral Inactivator

(2019) Xiaohuan Wang et al.   Viruses-Basel

Role of prophylactic azithromycin to reduce airway inflammation and mortality in a RSV mouse infection model

(2018) Ricardo A. Mosquera et al.   PEDIATRIC PULMONOLOGY

Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients

(2016) Mandy Menzel et al.   Scientific Reports

Repurposing an old drug: A low-cost allergy medication provides new hope for hepatitis C patients

(2015) Zhilei Chen et al.   HEPATOLOGY

Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis?

(2015) Avraham Beigelman et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection

(2015) Shanshan He et al.   Science Translational Medicine

Selective Inhibition of Hepatitis C Virus Infection by Hydroxyzine and Benztropine

(2014) Lidia Mingorance et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Macrolide Therapy in Respiratory Viral Infections

(2012) Jin-Young Min et al.   MEDIATORS OF INFLAMMATION

Clarithromycin Inhibits Type A Seasonal Influenza Virus Infection in Human Airway Epithelial Cells

(2009) M. Yamaya et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Azithromycin alters macrophage phenotype

(2008) B. S. Murphy et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY